EMAIL THIS PAGE TO A FRIEND

The Laryngoscope

Effect of inhibitor of tumor necrosis factor-alpha and oxatomide on immune mediated otitis media.


PMID 16954996

Abstract

Inflammatory mediators (IMs) play a major role in the production of middle ear effusion (MEE). Tumor necrosis factor (TNF)-alpha and leukotrienes (LTs) appear to be important in the pathogenesis of otitis media with effusion (OME). The purpose of this study is to determine the effect of TNF-alpha and LT antagonist on the outcome of experimental immune-mediated OME. Prospective. Otitis media was induced in rats by injecting keyhole limpet hemocyanin (KLH) transtympanically 7 days after systemic immunization. Experimental groups were treated with soluble TNF receptor type I (sTNF RI) or oxatomide simultaneously. Seventy-two hours after transtympanic injection, MEE was aspirated, and temporal bone was taken. Vascular permeability (VP) of the middle ear mucosa was measured using the Evans blue dye technique. Hematoxylin-eosin stain and immunohistochemical stain for leukocyte common antigen was performed. In KLH, sTNF RI, and oxatomide groups, MEE was developed in 83%, 0%, and 66% of the ears, respectively. The sTNF RI group showed significant decrease in effusion production, inflammation, mucosal thickening, and VP compared with the KLH group. These parameters were less significant in the oxatomide group than in the sTNF RI group. Transtympanic administration of sTNF RI and oxatomide appears to suppress the development of immune-mediated MEE.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

O9387 Oxatomide, ≥99%
C27H30N4O